News
By Reuters May 25, 20175:40 PM UTCUpdated ago May 25 (Reuters) - Anika Therapeutics Inc: * Anika announces first patient enrolled in supplemental phase III trial of CINGAL for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback